TrustCore Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
TrustCore Financial Services's GILD Position: Q4 2022 in Review
TrustCore Financial Services reduced its Gilead Sciences (GILD) stake by 8.9% in Q4 2022, selling an estimated $3.96K and leaving 509 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #479.
TrustCore Financial Services first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. The position peaked at $153K in Q1 2021. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.
- TrustCore Financial Services held 509 shares of Gilead Sciences worth $43.7K as of Q4 2022.
- TrustCore Financial Services sold 50 Gilead Sciences shares in Q4 2022, an estimated $3.96K.
- Gilead Sciences made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #479 holding.
- TrustCore Financial Services first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
- TrustCore Financial Services's Gilead Sciences position peaked at $153K in Q1 2021.
- 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.
Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.